Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (346)

Clear all filters
Clear all filters

Navicixizumab

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Navoximod

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)

Nimotuzumab (Head & Neck)

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Nirogacestat

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Solid Tumour (Sarcoma)

Drug Class / Mechanism

Gamma-Secretase / CDK Inhibitor

Nogapendekin Alfa Inbakicept

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Obrixtamig

Immunotherapy (Investigational)

Therapeutic Category

Immunotherapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Bispecific T-Cell Engager, DLL3 x CD3

Omburtamab

Targeted Therapy (Investigational Antibody)

Therapeutic Category

Targeted Therapy (Investigational Antibody)

Oncology Type

Solid Tumour (Neuroblastoma)

Drug Class / Mechanism

Radiolabelled Anti-B7-H3 Monoclonal Antibody (I-131)

Otlertuzumab

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Petosemtamab

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Pinatuzumab Vedotin

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

PRN1371 (Investigational FGFR)

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

FGFR Inhibitor

Raludotatug Deruxtecan

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Anti-CDH6 ADC, Topoisomerase I Inhibitor Payload